In‐depth analysis of the clinical significance of USP53 expression and tumor stages, ccRCC samples were divided into I‐II, III, and IV stages, the results showed that as tumor grade increases, USP53 expression decreases (Figure 1C). This evidence concerns the gene USP53 and neoplasm.